Vienna, Austria – Lexogen GmbH, a Vienna based Next-Generation Sequencing (NGS) and transcriptomics company, receives funding from the Austria Research Promotion Agency (FFG) for the development of a novel SARS-CoV-2 test method for mass screening. The company has already developed and commercialized multiple methods for high throughput RNA analysis and will base the test on its QuantSeq-Flex Targeted […]
Warburg Pincus brings strong healthcare experience and a global network to support innovation and scale-up as Polyplus serves the gene and cell therapy market. Illkirch, FRANCE –– Polyplus-transfection® SA (“Polyplus”), a developer of innovative and cost-effective technology used in gene and cell therapy, closed on a major investment from Warburg Pincus, a leading global private equity firm […]
LAUDA intensifies involvement with innovative start-up watttron Lauda-Königshofen – The LAUDA DR. R. WOBSER GmbH & Co. KG, the world market leader for precise temperature control, has renewed its support for the Saxon technology start-up watttron. Together with other renowned investors, LAUDA is providing fresh capital of EUR 3.4 million in addition to expertise. LAUDA […]
Researchers from Signature Science, Rice University, University of Maryland, and Fraunhofer USA Center for Experimental Software Engineering will transition the computational tools developed to predict the function and threat potential of short DNA sequences to the end user community. AUSTIN, TEXAS – Signature Science, LLC has been selected to continue their support of the Intelligence […]
PHILADELPHIA – The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular $1 million to enable the application of Integral Molecular’s technology platforms to aid in the discovery of vaccines and therapeutics to combat COVID-19. Integral Molecular’s Shotgun Mutagenesis Epitope Mapping platform precisely identifies where antibodies bind to their target proteins, and will be […]
London, UK / MicrofluidX announces it has raised £1.4m in seed funding from leading seed investors UK Innovation & Science Seed Fund (UKI2S), Longwall Ventures and Moulton Goodies Limited with angel contributions from 88 Capital and Cambridge Angels. The Company will develop its novel cell bioprocessing technology, utilising microfluidics to tackle the challenges associated with bioprocessing for cell […]
BELLEVUE, WA, US — DRVISION Technologies LLC, a pioneer in computer vision and the world’s leading AI microscopy software company has been awarded up to 2.16 million USD from the National Institute of General Medical Sciences (NIGMS) to develop the AI Restoring and Staining platform (AIRS). The R&D funded by this Fast-Track collaborative research grant (# […]
BURLINGAME, Calif.— Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has closed a $12M Series B1 financing round led by Research Corporation Technologies (RCT). The funding will be used for expanding Halo Labs’ world-wide Sales presence and the continued development of the company’s next-generation product portfolio. In addition, Halo Labs is […]
SAN CARLOS, Calif. — CellFE, Inc., an innovative startup developing a microfluidics based device to deliver gene-editing molecules, today announced it has completed a $4.8 million Series Seed round of financing. Dynamk Capital and Cota Capital co-led the investment round with participation from Embark Ventures, Elm Ventures and McEwan Lane Family Trust. Dr. Gustavo Mahler, Venture Partner, Dynamk Capital […]
Grant of $1 million used to finalize development and deployment of existing assay to triage coronavirus patients Toronto, Ontario, SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics (“SQI”), has been selected by University Health Network (“UHN”) investigators to […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
